Multiple myeloma epidemiology and demographics

Multiple myeloma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple Myeloma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Multiple myeloma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multiple myeloma epidemiology and demographics All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multiple myeloma epidemiology and demographics
CDC on Multiple myeloma epidemiology and demographics
Multiple myeloma epidemiology and demographics in the news
Blogs on Multiple myeloma epidemiology and demographics
Directions to Hospitals Treating Multiple myeloma
Risk calculators and risk factors for Multiple myeloma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In 2012, the incidence of multiple myeloma was approximately 6.3 per 100,000 cases with a mortality rate of 3.3 per 100,000 cases in the United States. The prevalence of multiple myeloma was estimated to be 89,658 cases in 2012 in the United States. Multiple myeloma is the second most common blood cancer after non-Hodgkin's lymphoma & 14th most common cancer overall in United States. Males are more commonly affected with multiple myeloma than females. Multiple myeloma usually affects individuals of the African American and Native Pacific Islanders race. Asian individuals are less likely to develop multiple myeloma. The incidence of multiple myeloma increases with age; the median age at diagnosis is between 65 to 70 years years. It is estimated that 77,617 people currently live with multiple myeloma in the United States.

Epidemiology and Demographics

Incidence

• In 2012, the incidence of multiple myeloma waws approximately 6.3 per 100,000 individuals with a case-fatality rate of 3.3 per 100,000 in the United States.
• In 2014, multiple myeloma constituted approximately 1.4 percent of the estimated new cancer cases.
• In 2015, the estimated incidence of multiple myeloma is 1.6% of all new cancer cases and 1.9% of all cancer mortality cases.
• Multiple myeloma is the 14th leading cause of cancer death in the United States.
• Since 1975, the overall multiple myeloma incidence has increased nearly 1 percent annually.

Prevalance

• Myeloma is the 14th leading cause of cancer death in the United States.
• Multiple myeloma is the second most prevalent blood cancer (10%) after non-Hodgkin's lymphoma.
• There are approximately 76,000 people in the United States living with multiple myeloma.
• Multiple myeloma represents approximately 1% of all cancers and 2% of all cancer deaths.
• In 2012, there were an estimated 89,658 people living with multiple myeloma in the United States.

Age

• The incidence of multiple myeloma increases with age; the median age at diagnosis is is 65 to 70 years. Though recent statistics indicate an increase in incidence of earlier age of onset in multiple myeloma.

Gender

• Multiple myeloma affects slightly more men than women.

Race

• Multiple myeloma usually affects individuals of the African American and Native Pacific Islanders race. Asian and Native Indian individuals are less likely to develop multiple myeloma.
• Among African Americans, multiple myeloma is one of the top 10 leading causes of cancer death.